Please use this identifier to cite or link to this item: http://hdl.handle.net/10419/129335
Authors: 
Ó Gráda, Cormac
Year of Publication: 
2015
Series/Report no.: 
Working Paper Series, UCD Centre for Economic Research 15/14
Abstract: 
Antimicrobial resistance (AMR) is currently the focus of much media attention and policy discussion. A historical perspective on AMR suggests that although the challenge of AMR is real, the doomsday tone of most commentary is unwarranted. That is partly because most of the gains in life expectancy now deemed under threat preceded the antibiotics revolution. A combination of public health measures, rising living standards, and new medical knowledge all played their part in this. Even if AMR increases, the continuing effect of these factors and of new public health measures can limit the negative consequences. Moreover, recent developments suggest that the supply pipeline of new drugs is not quite as dry as usually claimed. The problem for now is not MRSA or malaria but carbapenem-resistant gram-negative bacteria, which pose an urgent threat and on which public funding for research on effective new therapies should concentrate.
Subjects: 
infectious disease
health
antimicrobial resistance
economic history
JEL: 
I
N
Document Type: 
Working Paper

Files in This Item:
File
Size
441.18 kB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.